Enhancing innate immunity against virus in times of COVID-19: trying to untangle facts from fictions (Q100727426)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33072240 AND SRC:MED&resulttype=core&format=json

22 October 2020

title

Enhancing innate immunity against virus in times of COVID-19: trying to untangle facts from fictions (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33072240 AND SRC:MED&resulttype=core&format=json

22 October 2020

0 references

Désirée Larenas-Linnemann

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33072240 AND SRC:MED&resulttype=core&format=json

22 October 2020

Noel Rodríguez-Pérez

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33072240 AND SRC:MED&resulttype=core&format=json

22 October 2020

Alfredo Arias-Cruz

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33072240 AND SRC:MED&resulttype=core&format=json

22 October 2020

María Virginia Blandón-Vijil

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33072240 AND SRC:MED&resulttype=core&format=json

22 October 2020

Blanca E Del-Río-Navarro

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33072240 AND SRC:MED&resulttype=core&format=json

22 October 2020

Alan Estrada-Cardona

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33072240 AND SRC:MED&resulttype=core&format=json

22 October 2020

José E Gereda

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33072240 AND SRC:MED&resulttype=core&format=json

22 October 2020

Jorge A Luna-Pech

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33072240 AND SRC:MED&resulttype=core&format=json

22 October 2020

Elsy Maureen Navarrete-Rodríguez

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33072240 AND SRC:MED&resulttype=core&format=json

22 October 2020

Ernesto Onuma-Takane

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33072240 AND SRC:MED&resulttype=core&format=json

22 October 2020

César Fireth Pozo-Beltrán

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33072240 AND SRC:MED&resulttype=core&format=json

22 October 2020

María Isabel Rojo-Gutiérrez

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33072240 AND SRC:MED&resulttype=core&format=json

22 October 2020

publication date

9 October 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33072240 AND SRC:MED&resulttype=core&format=json

The World Allergy Organization Journal

22 October 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33072240 AND SRC:MED&resulttype=core&format=json

22 October 2020

page(s)

100476

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33072240 AND SRC:MED&resulttype=core&format=json

Estimation of the basic reproduction number, average incubation time, asymptomatic infection rate, and case fatality rate for COVID-19: Meta-analysis and sensitivity analysis

22 October 2020

cites work

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Preliminary prediction of the basic reproduction number of the Wuhan novel coronavirus 2019-nCoV

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

SARS coronavirus pathogenesis: host innate immune responses and viral antagonism of interferon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

COVID-19: consider cytokine storm syndromes and immunosuppression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Therapeutic Potential of B-1a Cells in COVID-19

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Moderate to vigorous physical activity and risk of upper-respiratory tract infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Physical Activity, Stress, and Self-Reported Upper Respiratory Tract Infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

The symptomatology of upper respiratory tract infections and exercise in elderly people.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Exercise and the aging immune system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Moderate Exercise Enhances the Production of Interferon-γ and Interleukin-12 in Peripheral Blood Mononuclear Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Acute exercise mobilises CD8 T lymphocytes exhibiting an effector-memory phenotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Exercise-induced redistribution of T lymphocytes is regulated by adrenergic mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

T-regulatory cells exhibit a biphasic response to prolonged endurance exercise in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Exercise and psychosocial factors modulate immunity to influenza vaccine in elderly individuals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Toll-Like Receptor 3 Signaling via TRIF Contributes to a Protective Innate Immune Response to Severe Acute Respiratory Syndrome Coronavirus Infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Influence of exercise training and age on CD14 cell-surface expression of toll-like receptor 2 and 4.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Exercise amelioration of depression-like behavior in OVX mice is associated with suppression of NLRP3 inflammasome activation in hippocampus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Does exercise increase the risk of upper respiratory tract infections?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Exercise, infection, and immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Debunking the Myth of Exercise-Induced Immune Suppression: Redefining the Impact of Exercise on Immunological Health Across the Lifespan.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Phytoncides (wood essential oils) induce human natural killer cell activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Forest bathing enhances human natural killer activity and expression of anti-cancer proteins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Visiting a forest, but not a city, increases human natural killer activity and expression of anti-cancer proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Effect of phytoncide from trees on human natural killer cell function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Using psychoneuroimmunity against COVID-19

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Gαs-coupled receptor signaling and sleep regulate integrin activation of human antigen-specific T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Number and function of circulating human antigen presenting cells regulated by sleep.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

REM sleep deprivation in rats results in inflammation and interleukin-17 elevation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Effects of acute and chronic sleep loss on immune modulation of rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Sleep disturbance and older adults' inflammatory responses to acute stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Effect of Sleep Deprivation on Response to Immunizaton

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Sleep habits and susceptibility to the common cold

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Behaviorally Assessed Sleep and Susceptibility to the Common Cold

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Psychological Stress and Susceptibility to the Common Cold

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Relationships between mindfulness practice and levels of mindfulness, medical and psychological symptoms and well-being in a mindfulness-based stress reduction program

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Meditation or exercise for preventing acute respiratory infection: a randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Epidemic influenza and vitamin D

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Vitamin D and the intracrinology of innate immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

The interplay between vitamin D and viral infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Vitamin D in allergic disease: shedding light on a complex problem

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Vitamin D and Respiratory Tract Infections: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Effect of Vitamin D3 Supplementation on Respiratory Tract Infections in Healthy Individuals: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Vitamin D supplementation for the prevention of childhood acute respiratory infections: a systematic review of randomised controlled trials.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Enhancing immunity in viral infections, with special emphasis on COVID-19: A review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Vitamin-D and COVID-19: do deficient risk a poorer outcome?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Vitamin D: deficiency, sufficiency and toxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Intravenous Vitamin C for reduction of cytokines storm in Acute Respiratory Distress Syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Vitamin C Is an Essential Factor on the Anti-viral Immune Responses through the Production of Interferon-α/β at the Initial Stage of Influenza A Virus (H3N2) Infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Vitamin C and common cold-induced asthma: a systematic review and statistical analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

A Novel Combination of Vitamin C, Curcumin and Glycyrrhizic Acid Potentially Regulates Immune and Inflammatory Response Associated with Coronavirus Infections: A Perspective from System Biology Analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Hypovitaminosis C and vitamin C deficiency in critically ill patients despite recommended enteral and parenteral intakes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Vitamin C and coronavirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Functional Role of Dietary Intervention to Improve the Outcome of COVID-19: A Hypothesis of Work

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Flavonoids from Houttuynia cordata attenuate H1N1-induced acute lung injury in mice via inhibition of influenza virus and Toll-like receptor signalling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Individual risk management strategy and potential therapeutic options for the COVID-19 pandemic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

The clinical benefits of Chinese patent medicines against COVID-19 based on current evidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Traditional Chinese Medicine in the Treatment of Patients Infected with 2019-New Coronavirus (SARS-CoV-2): A Review and Perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Pharmacologic perspective: glycyrrhizin may be an efficacious therapeutic agent for COVID-19

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

The Role of Zinc in Antiviral Immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Zinc in human health: effect of zinc on immune cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Role of zinc administration in prevention of childhood diarrhea and respiratory illnesses: a meta-analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Low zinc status: a new risk factor for pneumonia in the elderly?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Prevention of diarrhea and pneumonia by zinc supplementation in children in developing countries: pooled analysis of randomized controlled trials. Zinc Investigators' Collaborative Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Zinc supplementation for the prevention of acute lower respiratory infection in children in developing countries: meta-analysis and meta-regression of randomized trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Zinc lozenges may shorten the duration of colds: a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Fever and the thermal regulation of immunity: the immune system feels the heat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Fever-like thermal conditions regulate the activation of maturing dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Conservation of IL-6 trans-signaling mechanisms controlling L-selectin adhesion by fever-range thermal stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

From fever to immunity: A new role for IGFBP-6?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Circulating cytokines as mediators of fever

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Activation of the sympathetic nervous system modulates neutrophil function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

The regulation of interleukin-6 implicates skeletal muscle as an integrative stress sensor and endocrine organ

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Functional expression of TRPV channels in T cells and their implications in immune regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

The acute phase protein haptoglobin regulates host immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Heat therapy: an ancient concept re-examined in the era of advanced biomedical technologies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Passive heat therapy protects against endothelial cell hypoxia-reoxygenation via effects of elevations in temperature and circulating factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

The effect of antipyretic therapy upon outcomes in critically ill patients: a randomized, prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Antipyretic drugs in patients with fever and infection: literature review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Therapeutic targeting of trained immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

BCG-induced trained immunity in NK cells: Role for non-specific protection to infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Innate immune memory: a paradigm shift in understanding host defense.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Trained immunity: A program of innate immune memory in health and disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Human dendritic cells activated with MV130 induce Th1, Th17 and IL-10 responses via RIPK2 and MyD88 signalling pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

MV140, a sublingual polyvalent bacterial preparation to treat recurrent urinary tract infections, licenses human dendritic cells for generating Th1, Th17, and IL-10 responses via Syk and MyD88.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Modulation of Myelopoiesis Progenitors Is an Integral Component of Trained Immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Efficacy of Whole‐Cell Killed Bacterial Vaccines in Preventing Pneumonia and Death during the 1918 Influenza Pandemic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Sublingual therapeutic immunization with a polyvalent bacterial preparation in patients with recurrent respiratory infections: immunomodulatory effect on antigen-specific memory CD4 T cells and impact on clinical outcome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Primary prevention of severe lower respiratory illnesses in at-risk infants using the immunomodulator OM-85

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Trained immunity in newborn infants of HBV-infected mothers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Probiotics and the Gut Immune System: Indirect Regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Beneficial Effects of Probiotic Consumption on the Immune System

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Immunobiotic Strains Modulate Toll-Like Receptor 3 Agonist Induced Innate Antiviral Immune Response in Human Intestinal Epithelial Cells by Modulating IFN Regulatory Factor 3 and NF-κB Signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Prospective study of probiotic supplementation results in immune stimulation and improvement of upper respiratory infection rate.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Probiotics and Paraprobiotics in Viral Infection: Clinical Application and Effects on the Innate and Acquired Immune Systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Probiotics and COVID-19: one size does not fit all

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Effectiveness of probiotics on the duration of illness in healthy children and adults who develop common acute respiratory infectious conditions: a systematic review and meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Serum and fecal profiles of aromatic microbial metabolites reflect gut microbiota disruption in critically ill patients: a prospective observational pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Is diet partly responsible for differences in COVID-19 death rates between and within countries?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

The cellular transfer of cutaneous hypersensitivity to tuberculin in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

CD8 T cells produce a dialyzable antigen-specific activator of dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

The dialyzable leukocyte extract Transferon TM inhibits tumor growth and brain metastasis in a murine model of prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Dialyzable Leukocyte Extract (Transferon™) Administration in Sepsis: Experience from a Single Referral Pediatric Intensive Care Unit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Serum Derived Transfer Factor Stimulates the Innate Immune System to Improve Survival Traits in High Risk Pathogen Scenarios.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Adjuvant treatment using transfer factor for bronchogenic carcinoma: long-term follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Immunostimulants in respiratory diseases: focus on Pidotimod

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Pidotimod stimulates natural killer cell activity and inhibits thymocyte cell death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

The Synthetic Dipeptide Pidotimod Shows a Chemokine-Like Activity through CXC Chemokine Receptor 3 (CXCR3)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Pidotimod promotes functional maturation of dendritic cells and displays adjuvant properties at the nasal mucosa level.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Immunomodulatory effects of pidotimod in adults with community-acquired pneumonia undergoing standard antibiotic therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Pidotimod, an immunostimulant in pediatric recurrent respiratory tract infections: A meta-analysis of randomized controlled trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Safety and Immunogenicity of Early Bacillus Calmette-Guérin Vaccination in Infants Who Are Preterm and/or Have Low Birth Weights: A Systematic Review and Meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Nonspecific (Heterologous) Protection of Neonatal BCG Vaccination Against Hospitalization Due to Respiratory Infection and Sepsis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Early BCG-Denmark and Neonatal Mortality Among Infants Weighing <2500 g: A Randomized Controlled Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

BCG Vaccination Enhances the Immunogenicity of Subsequent Influenza Vaccination in Healthy Volunteers: A Randomized, Placebo-Controlled Pilot Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

BCG Vaccination Protects against Experimental Viral Infection in Humans through the Induction of Cytokines Associated with Trained Immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

BCG vaccine protection from severe coronavirus disease 2019 (COVID-19)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

SARS-CoV-2 Rates in BCG-Vaccinated and Unvaccinated Young Adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

BCG-induced trained immunity: can it offer protection against COVID-19?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Heterologous Immunity: Role in Natural and Vaccine-Induced Resistance to Infections.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Vaccination and heterologous immunity: educating the immune system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Non-specific Effect of Vaccines: Immediate Protection against Respiratory Syncytial Virus Infection by a Live Attenuated Influenza Vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Vitamin D supplementation and risk of respiratory tract infections: a meta-analysis of randomized controlled trials.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Effect of Vitamin C Infusion on Organ Failure and Biomarkers of Inflammation and Vascular Injury in Patients With Sepsis and Severe Acute Respiratory Failure: The CITRIS-ALI Randomized Clinical Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Enteral Omega-3 Fatty Acid, γ-Linolenic Acid, and Antioxidant Supplementation in Acute Lung Injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Association of BCG, DTP, and measles containing vaccines with childhood mortality: systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

Thirty-six COVID-19 cases preventively vaccinated with mumps-measles-rubella vaccine: all mild course

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.WAOJOU.2020.100476

10.1016/J.WAOJOU.2020.100476

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33072240 AND SRC:MED&resulttype=core&format=json

22 October 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33072240 AND SRC:MED&resulttype=core&format=json

22 October 2020

PubMed publication ID

33072240

1 reference